Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for North Carolina by County

Non-Hodgkin Lymphoma (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


North Carolina6


US (SEER+NPCR)1


Jackson County6


Burke County6


Edgecombe County6


Carteret County6


Pasquotank County6


Polk County6


Nash County6


Halifax County6


Dare County6


Hoke County6


Transylvania County6


Cherokee County6


Catawba County6


Scotland County6


Macon County6


Caswell County6


Pitt County6


Iredell County6


Richmond County6


Watauga County6


Surry County6


Moore County6


Vance County6


Anson County6


Wilson County6


Columbus County6


McDowell County6


Cumberland County6


Bertie County6


Franklin County6


Durham County6


Buncombe County6


Randolph County6


Robeson County6


Sampson County6


Brunswick County6


Lee County6


Yadkin County6


Duplin County6


Wayne County6


Person County6


Rockingham County6


Harnett County6


Beaufort County6


Rutherford County6


Cleveland County6


Mecklenburg County6


Wilkes County6


Guilford County6


Forsyth County6


New Hanover County6


Yancey County6


Stokes County6


Greene County6


Rowan County6


Davidson County6


Caldwell County6


Union County6


Johnston County6


Wake County6


Pender County6


Alamance County6


Cabarrus County6


Davie County6


Madison County6


Gaston County6


Martin County6


Stanly County6


Onslow County6


Haywood County6


Granville County6


Alexander County6


Bladen County6


Craven County6


Lenoir County6


Ashe County6


Avery County6


Montgomery County6


Lincoln County6


Henderson County6


Orange County6


Chatham County6


Swain County6


Alleghany County6 Camden County6 Chowan County6 Clay County6 Currituck County6 Gates County6 Graham County6 Hertford County6 Hyde County6 Jones County6 Mitchell County6 Northampton County6 Pamlico County6 Perquimans County6 Tyrrell County6 Warren County6 Washington County6

Notes:
Created by statecancerprofiles.cancer.gov on 12/08/2023 5:42 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.